Compare UI & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UI | KVUE |
|---|---|---|
| Founded | 2003 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Specialty Chemicals |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.8B | 39.9B |
| IPO Year | 2011 | 2023 |
| Metric | UI | KVUE |
|---|---|---|
| Price | $554.11 | $17.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 13 |
| Target Price | ★ $587.50 | $20.31 |
| AVG Volume (30 Days) | 128.6K | ★ 37.7M |
| Earning Date | 11-07-2025 | 11-03-2025 |
| Dividend Yield | 0.57% | ★ 4.79% |
| EPS Growth | ★ 102.50 | 35.31 |
| EPS | ★ 13.07 | 0.75 |
| Revenue | $2,756,974,000.00 | ★ $15,006,000,000.00 |
| Revenue This Year | $15.29 | N/A |
| Revenue Next Year | $8.93 | $2.81 |
| P/E Ratio | $42.95 | ★ $23.18 |
| Revenue Growth | ★ 36.77 | N/A |
| 52 Week Low | $255.00 | $14.02 |
| 52 Week High | $803.60 | $25.17 |
| Indicator | UI | KVUE |
|---|---|---|
| Relative Strength Index (RSI) | 37.76 | 58.74 |
| Support Level | $549.69 | $16.70 |
| Resistance Level | $595.00 | $17.59 |
| Average True Range (ATR) | 21.85 | 0.30 |
| MACD | 4.56 | 0.02 |
| Stochastic Oscillator | 24.30 | 60.27 |
Ubiquiti Inc is a seller of equipment and provides the related software platforms through web stores. The group develops technology platforms for high-capacity distributed Internet access, unified information technology, and consumer electronics for professional, home, and personal use. Its solutions are: high-performance networking technology for enterprises, service providers, and consumers. target the enterprise and service provider markets through a community of service providers, distributors, value-added resellers, webstores, systems integrators, and corporate IT professionals, which it refers to as the Ubiquiti Community. It targets consumers through digital marketing, including through webstores, retail chains, and, to a lesser extent, the Ubiquiti Community.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.